Harnessing the power of precision medicine to conquer Alzheimer’s disease

ProMIS Neurosciences announces identification of a fourth novel therapeutic target for Alzheimer’s disease

| News | No Comments

ProMIS Neurosciences announces identification of a fourth novel therapeutic target for Alzheimer’s disease Novel target is fourth in a series of potential targets on strains of misfolded Amyloid beta, implicated in the development and progression of Alzheimer’s TSX: PMN TORONTO, May 5, 2016 /CNW/ – ProMIS Neurosciences (“ProMIS” or the…

Company Overview

Learn More

Our Team

Learn More

Company News

Learn More